Page 2 - Cyte Corporation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OncoCyte (NASDAQ:OCX) Research Coverage Started at StockNews com

OncoCyte (NASDAQ:OCX) Research Coverage Started at StockNews com
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew arnoNeedham companySecurities exchange commissionOncocyte corporationFree reportBroadwood partnersDirector andrew arnoExchange commissionGet free reportCyte corporationOncocyte daily

OncoCyte (NASDAQ:OCX) Receives New Coverage from Analysts at StockNews com

OncoCyte (NASDAQ:OCX) Receives New Coverage from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew arnoOncocyte corporationSecurities exchange commissionNeedham companyFree reportDirector andrew arnoBroadwood partnersExchange commissionGet free reportCyte corporationOncocyte daily

OncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at StockNews com

OncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew arnoNeedham companyOncocyte corporationSecurities exchange commissionOncocyte company profileFree reportDirector andrew arnoExchange commissionBroadwood partnersGet free reportCyte corporationOncocyte daily

StockNews com Begins Coverage on OncoCyte (NASDAQ:OCX)

StockNews com Begins Coverage on OncoCyte (NASDAQ:OCX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew arnoOncocyte corporationSecurities exchange commissionFree reportBroadwood partnersExchange commissionDirector andrew arnoGet free reportCyte corporationOncocyte daily

OncoCyte (NASDAQ:OCX) PT Raised to $4 25 at Needham & Company LLC

OncoCyte (NASDAQ:OCX – Get Free Report) had its target price increased by equities researchers at Needham & Company LLC from $3.60 to $4.25 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside […]

United statesAndrew arnoOncocyte company profileNeedham companyOncocyte corporationSecurities exchange commissionGet free reportCyte trading downDirector andrew arnoBroadwood partnersExchange commissionCyte corporationOncocyte daily